Rossmore Private Capital
Source: SEC Form 13F · as of Mar 2026Rossmore Private Capital holds 18 biotech & pharma companies tracked by BioSniper, totaling $91.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$91.1M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 100,354 | $24.5M |
| LLYELI LILLY & Co | 20,770 | $19.1M |
| ABBVAbbVie Inc. | 48,197 | $10.5M |
| MCKMcKesson Corporation | 8,107 | $7.0M |
| MRKMerck & Co., Inc. | 57,421 | $7.0M |
| AZNASTRAZENECA PLC | 33,683 | $6.5M |
| ABTABBOTT LABORATORIES | 47,288 | $4.9M |
| PMPhilip Morris International Inc | 26,977 | $4.5M |
| AMGNAMGEN INC | 5,635 | $2.0M |
| GILDGILEAD SCIENCES, INC. | 7,582 | $1.1M |
| NVONovo Nordisk A/S | 23,000 | $873K |
| PFEPFIZER INC | 25,793 | $724K |
| NVSNovartis AG | 4,581 | $700K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,284 | $618K |
| CORCencora Inc. | 1,488 | $467K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 4,518 | $252K |
| TECHBIO-TECHNE Corp | 4,000 | $209K |
| ZTSZoetis Inc. | 1,730 | $205K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.